China Resources Pharmaceutical Commercial Group Co (CRPCG)

PhillipCapital 'remains confident' in iX Biopharma’s growth prospects upon China agreement - THE EDGE SINGAPORE

Broker's Calls

PhillipCapital 'remains confident' in iX Biopharma’s growth prospects upon China agreement

PhillipCapital has kept its "buy" recommendation with the same target price of 44.5 cents.
×